Immunitas Therapeutics logo

Immunitas Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

Immunitas Therapeutics is a biotechnology research company focused on discovering and developing novel therapeutics for cancer and autoimmune diseases. Its lead program, IMT-009, targets CD161 and is in clinical trials for patients with refractory tumors across indications such as MSS colorectal cancer, head and neck cancer, and non-small cell lung cancer. Its second program aims to treat autoimmune disease and builds on its work with the CD161-CLEC2D pathway. It is based in Waltham, Massachusetts, and operates as a small to mid-sized organization.

In addition to its internal programs, the company has engaged in partnerships, including a global licensing agreement announced in 2026 with Boehringer Ingelheim aimed at a preclinical antibody program for chronic inflammatory and autoimmune diseases. Immunitas has shared data on IMT-009, including phase 1/2a results indicating anti-tumor activity, at scientific meetings such as AACR 2026.

Find Immunitas Therapeutics employees' phone numbers or email addresses

Immunitas Therapeutics Global Highlights

Location
Employees

North America
21

Minus sign iconPlus sign icon
  • United States Of America
    21

Europe
2

Minus sign iconPlus sign icon
  • Latvia
    1
  • Switzerland
    1

Immunitas Therapeutics's Leadership

  • Stylized image of a person
    D. M.
    Consultant
    Phone icon

Immunitas Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Consultant
  • Operations
  • Administrative
  • Biotechnology
  • Other
  • Engineering
  • Healthcare Services
  • Business Development
  • Business
  • Entrepreneurship
  • Community & Social Services

Contact profiles from Immunitas Therapeutics

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    D. M.
    Consultant
    Phone icon
    Oct 24, 2024

Frequently Asked Questions

What is Immunitas Therapeutics known for?

Minus sign iconPlus sign icon
Immunitas Therapeutics was founded in 2019 operates in the Biotechnology Research industry. Explore Immunitas Therapeutics's company overview page for more information.

What is Immunitas Therapeutics's most common email format?

Minus sign iconPlus sign icon
Immunitas Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Immunitas Therapeutics email formats with LeadIQ.

How many employees does Immunitas Therapeutics have currently?

Minus sign iconPlus sign icon
Immunitas Therapeutics has approximately 22 employees as of July 2026. These team members are located across 2 continents, including North AmericaEurope.

Who are Immunitas Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Immunitas Therapeutics's key employees include:

  • Consultant: D. M.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.